1. Montes-Moreno S, Odqvist L, Diaz-Perez JA, Lopez AB, de Villambrosía SG, Mazorra F, et al. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive postgerminal center B-cell neoplasm characterized by prominent nuclear factor-kB activation. Mod Pathol 2012;25(7):968–82. [
DOI] [
PubMed]
2. Azhar M, Din H, Muhammad I, Hashmi SN, Akhtar F. Frequency of Epstein Barr virus in classical Hodgkin lymphoma. J Ayub Med Coll Abbottabad 2016;28(2):271–5. [
PubMed]
3. Cickusic E, Mustedanagic-Mujanovic J, Iljazovic E, Karasalihovic Z, Skaljic I. Association of Hodgkin lymphoma with Epstein Barr virus infection. BJBMS 2007; 7(1):58-65.
4. Re D, Kuppers R, Diehl V. Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol 2005;23(26):6379-86. [
DOI] [
PubMed]
5. Küppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003;3(10):801-12. [
DOI] [
PubMed]
6. Mozafari L, Najafipour S, Meshkibaf MH, Moravej A. Analysis of the presence of Epstein-Barr virus in Hodgkin's lymphoma in Iranian children by EBER in situ hybridization. Par J Med Sci 2014;12(2):57-63. [
DOI]
7. Alebouyeh M, Vossough P. Hodgkin disease in Iranian children. Eur J Pediatr 1993; 152(1):21-3. [
DOI] [
PubMed]
8. Fu Q, He C, Mao ZR. Epstein-Barr virus interactions with the Bcl 2 protein family and apoptosis in human tumor cells. J Zhejiang Univ Sci B 2013;14(1):8–24. [
DOI] [
PubMed]
9. Brocqueville G, Ndour PA, Ouk TS, Le Goff A, De Witte C, Mougel A, et al. LMP1- induced cell death may contribute to the emergency of its oncogenic property. PLoS One 2013;8(4):e60743. [
DOI] [
PubMed]
10. Salamon D, Adori M, Ujvari D, Wu L, Kis LL, Madapura HS, et al. Latency type- dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells. J Virol 2012;86(8):4701–7. [
DOI] [
PubMed]
11. Shariat A. Detection of LMP1 protein in Breast Cancer tissue samples from Fars province hospitals. Iran J Med Microbiol 2017;11(1):67-74.
12. Engel M, Essop MF, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin’s lymphoma: study of 47 South African cases. J Clin Pathol 2000;53(3):182–6. [
DOI] [
PubMed]
13. Mohamed G, Vrzalikova K, ZumlaCader F, Vockerodt M, Nagy E, Flodr P, et al. Epstein–Barr virus, the germinal centre and the development of Hodgkin’s lymphoma. J Gen Virol 2014;95(9):1861–9. [
DOI] [
PubMed]
14. Jarrett AF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996;7(4):S5-S10. [
DOI]
15. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med. 2008;264(6):537-48. [
DOI] [
PubMed]
16. Katebi M, Sharifi N, Tarhini M, Otrock ZK, Bazarbachi A, Kchour G. Frequency of Epstein-Barr virus expression in various histological subtypes of Hodgkin's lymphoma. Histopathology 2008;52(6):775-7. [
DOI] [
PubMed]
17. Najafipour S, Mokhtari Azad T, Kousari F, Mahmoodi M, Nategh R. Association of Epstein-Barr Virus and Hodgkin’s Disease. Acta Medica Iranica 2003;41(1):1-10.
18. Mozafari L, Najafipour S, Meshkibaf MH, Moravej A. Expression of Epstein-Barr virus in Hodgkin lymphoma Specimens in IRAN. JFUMS 2013;3(2):143-8.
19. Jadali F, Karimi A, Fallah F, Habibi G, Shamshiri A, Gharib A, et al. Detection of Epstein-Barr virus in Pediatric Hodgkin's Lymphoma in Iran by immunohistochemistry and in situ hybridization. Cancer Ther 2008;6(2):665-71.
20. Grywalskaand E, Rolinski J. Epstein-Barr Virus–Associated Lymphomas. Semin Oncol 2015;42(2):291-303. [
DOI] [
PubMed]